Precision Medicine in Low- and Middle-Income Countries

Abstract

Dr. Julie Gralow delivered the plenary session on the topic “Precision Medicine in Low- and Middle-Income Countries” during session 7. She explored the barriers to precision oncology in low and middle-income countries. She detailed the examples of initiatives that have improved the availability and accessibility of cancer medicines, such as the World Health Organization model list of essential medicines, the Max Foundation, and the Union for International Cancer Control Access to Oncology Medicines Coalition. She also discussed initiatives that have improved access to diagnostics in low and middle-income countries, such as The American Society of Clinical Pathology Partners for Cancer Diagnosis and Treatment in Africa and the “Spot on CML” test. Some methods to increase the capacity and infrastructure for precision medicine, such as molecular tumor boards and the National Cancer Grid of India, were also discussed. She closed her talk with an appeal to push for equitable access to precision medicine through international cooperation. Following her address, a question-and-answer session brought an end to session 7.